Cowen Starts Allena Pharmaceuticals (ALNA) at Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cowen Starts Allena Pharmaceuticals (ALNA) at Outperform

Wedbush Starts Allena Pharmaceuticals (ALNA) at Outperform; Sees $3B Blockbuster Sales Potential from ALLN-177

November 27, 2017 6:32 AM EST

Wedbush initiates coverage on Allena Pharmaceuticals (NASDAQ: ALNA) with a Outperform rating and a price target of $30.00.

Analyst Liana Moussatos sees ALNA as an opportunity to invest in oral enzyme treatments for patients with severe metabolic and kidney disorders.

They project cash... More

Jefferies Starts Allena Pharmaceuticals (ALNA) at Buy

November 27, 2017 2:08 AM EST

Jefferies initiates coverage on Allena Pharmaceuticals (NASDAQ: ALNA) with a Buy rating and a price target of $22.00.

Analyst Matt Andrews believes the company's drug, ALLN-177, will be "The Next Big Metabolic Enzyme Blockbuster."

For an analyst ratings summary and ratings history on... More